Feed 600267.SS
60
Zhejiang Hisun Pharmaceutical Co., Ltd.
600267.SS · SHH
¥14.15 +1.36% (+¥0.19)
1M +13.90%
Market Cap ¥16.7B
P/E Ratio 23.78x
Div. Yield 1.48%
ROE 8.16%
Bulios Fair Price
¥20.29
43.4% upside
Current Price
¥14.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 600267.SS is currently undervalued relative to its market price. How does it work?
Piotroski F-Score Strong
8/9Valuation
73 /100
Cheap P/E 23.78x
EV/EBITDA 13.20x
P/S 1.62x
Growth
23 /100
Declining EPS growth 3.08%
Rev. growth 4.30%
FCF growth 2.54%
Profitability
69 /100
Strong Gross margin 46.45%
Net margin 6.81%
Op. margin 8.98%
Quality
40 /100
Average ROIC 5.81%
ROE 8.16%
ROA 5.08%
Debt
90 /100
Low Debt/Equity 0.16x
Current ratio 1.00x
Int. coverage 11.26x
Stability
37 /100
Moderate Beta 0.28x
Rev. volatility 10.91%
EPS volatility 473.77%
Ask StockBot about 600267.SS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Weihong Xiao
Employees
8,751
Headquarters
Taizhou
Upcoming events
26 AUG
Earnings
Upcoming earnings report